[
    {
        "molecule_name": "[3H]-prazosin",
        "protein_target_name": "α1A adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0.46",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with bioactivity metrics (IC50, Ki, Kd, EC50) along with specific numeric values and units:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3).\nThe Kd value was used to calculate Ki of LDT's using the Cheng-Prusoff equation, with Kd = 1.77 ± 0.07 nM for 5-HT2A receptors.\nKi values were calculated using the Cheng-Prusoff equation, with Kd = 0.7 nM ± 0.1 nM for 5-HT1A receptors.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values in nM.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values in nM.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values in nM.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values in µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values in nM.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values in nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki values in nM.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values in M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values in nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values in µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki values in nM.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values in µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values in µM."
    },
    {
        "molecule_name": "[3H]-prazosin",
        "protein_target_name": "α1A adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "56.5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with bioactivity metrics (IC50, Ki, Kd, EC50) along with specific numeric values and units:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3).\nThe Kd value was used to calculate Ki of LDT's using the Cheng-Prusoff equation, with Kd = 1.77 ± 0.07 nM for 5-HT2A receptors.\nKi values were calculated using the Cheng-Prusoff equation, with Kd = 0.7 nM ± 0.1 nM for 5-HT1A receptors.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values in nM.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values in nM.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values in nM.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values in µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values in nM.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values in nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki values in nM.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values in M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values in nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values in µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki values in nM.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values in µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values in µM."
    },
    {
        "molecule_name": "LDT's",
        "protein_target_name": "5-HT2A receptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "1.77 ± 0.07",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with bioactivity metrics (IC50, Ki, Kd, EC50) along with specific numeric values and units:\n\n\nThe values of Kd and Bmax were 2.05 ± 0.28 nM and 124 ± 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 ± 0.1 nM and 125 ± 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nKd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3).\nThe Kd value was used to calculate Ki of LDT's using the Cheng-Prusoff equation, with Kd = 1.77 ± 0.07 nM for 5-HT2A receptors.\nKi values were calculated using the Cheng-Prusoff equation, with Kd = 0.7 nM ± 0.1 nM for 5-HT1A receptors.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the α1A-adrenoceptors, with Ki values in nM.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) α1B adrenoceptor, with Ki values in nM.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in α1A and α1B adrenoceptor, with Ki values in nM.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in α2A receptors, with Ki values in µM.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values in nM.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values in nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki values in nM.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values in M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values in nM.\nTable 12: Pharmacological parameters of the LDT's on α2A receptors, with Ki values in µM.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki values in nM.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values in µM.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values in µM."
    }
]